Optometry Research Today is a free monthly online journal that collates and summarizes the latest research about Optometry, including details on myopia, optometric practice, therapy.

Volume 2 (2006), Issue 6 (June)

1. Decreased pigment epithelium-derived factor expression in human breast cancer progression.
   Clin Cancer Res, 12(11): 3510-7. [Abstract] [Full-text]
2. P-Glycoprotein expression in human retinal pigment epithelium cell lines.
   Exp Eye Res, 83(1): 24-30. [Abstract] [Full-text]
3. Evaluation of the high specificity Screening Program (C-20-1) of the Frequency Doubling Technology (FDT) perimeter in clinical practice.
   Eye, 20(6): 681-7. [Abstract] [Full-text]
4. Low vision rehabilitation services in Michigan viewed against the national backdrop.
   Can J Ophthalmol, 41(3): 378-88. [Abstract] [Full-text]
5. Low vision service models in Alberta: innovation, collaboration, and future opportunities.
   Can J Ophthalmol, 41(3): 373-7. [Abstract] [Full-text]
6. Quebec model for low vision rehabilitation.
   Can J Ophthalmol, 41(3): 362-6. [Abstract] [Full-text]
7. Perspectives on low vision service in Canada: a pilot study.
   Can J Ophthalmol, 41(3): 348-54. [Abstract] [Full-text]
8. Principles of modern low vision rehabilitation.
   Can J Ophthalmol, 41(3): 289-312. [Abstract] [Full-text]
9. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
   Am J Ophthalmol, 141(6): 1051-6. [Abstract] [Full-text]
10. Prevalence of trachoma and diabetes-related eye disease among a cohort of adult Aboriginal patients screened over the period 1999-2004 in remote South Australia.
    Clin Experiment Ophthalmol, 34(4): 329-34. [Abstract] [Full-text]
11. Visual field defects and retinal ganglion cell losses in patients with glaucoma.
    Arch Ophthalmol, 124(6): 853-9. [Abstract] [Full-text]
12. Changes in implicit time of the multifocal electroretinogram response following contrast adaptation.
    Curr Eye Res, 31(6): 549-56. [Abstract] [Full-text]
13. The skew ray issue in ocular aberration measurement.
    Optom Vis Sci, 83(6): 396-8. [Abstract] [Full-text]
14. The repeatability of corneal and corneal epithelial thickness measurements using optical coherence tomography.
    Optom Vis Sci, 83(6): 360-5. [Abstract] [Full-text]
15. The effect of overnight contact lens corneal reshaping on refractive error-specific quality of life.
    Optom Vis Sci, 83(6): 354-9. [Abstract] [Full-text]
16. Validation of the PowerRefractor for measuring human infant refraction.
    Optom Vis Sci, 83(6): 346-53. [Abstract] [Full-text]
17. The Charles F. Prentice Award Lecture 2005: optics of the human eye: progress and problems.
    Optom Vis Sci, 83(6): 335-45. [Abstract] [Full-text]
18. Novel pachometry calibration.
    Optom Vis Sci, 83(6): 366-71. [Abstract] [Full-text]
19. Spatial resolution for feature binding is impaired in peripheral and amblyopic vision.
    J Neurophysiol, 96(1): 142-53. [Abstract] [Full-text]
20. Age-related macular degeneration.
    J Br Menopause Soc, 12(2): 64-70. [Abstract] [Full-text]
21. Optic disc pit: primary diagnosis in a child.
    Clin Exp Optom, 89(4): 257-9. [Abstract] [Full-text]
22. Large interface particles from LASIK surgery.
    Clin Exp Optom, 89(4): 253-6. [Abstract] [Full-text]
23. Attention, reading and dyslexia.
    Clin Exp Optom, 89(4): 241-5. [Abstract] [Full-text]
24. The Australian optometric workforce 2005.
    Clin Exp Optom, 89(4): 229-40. [Abstract] [Full-text]
25. Measuring mobility performance: experience gained in designing a mobility course.
    Clin Exp Optom, 89(4): 215-28. [Abstract] [Full-text]
26. Inhibiting the transient choroidal thickening response using the nitric oxide synthase inhibitor l-NAME prevents the ameliorative effects of visual experience on ocular growth in two different visual paradigms.
    Exp Eye Res, 83(2): 456-64. [Abstract] [Full-text]
27. The ultrastructure of superficial hypertrophic dendriform epitheliopathy after keratoplasty.
    Cornea, 25(5): 623-7. [Abstract] [Full-text]
28. Absence of alpha3 (Cx46) and alpha8 (Cx50) connexins leads to cataracts by affecting lens inner fiber cells.
    Exp Eye Res, 83(3): 688-96. [Abstract] [Full-text]
29. Temporal changes in the tear menisci following a blink.
    Exp Eye Res, 83(3): 517-25. [Abstract] [Full-text]
30. Promising new treatments for neovascular age-related macular degeneration.
    Expert Opin Investig Drugs, 15(7): 779-93. [Abstract] [Full-text]
31. Digital area measurement of fundus landmarks.
    Graefes Arch Clin Exp Ophthalmol, 244(6): 649-53. [Abstract] [Full-text]
32. Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.
    Infect Immun, 74(7): 3880-9. [Abstract] [Full-text]
33. Towards comprehensive population-based screening for diabetic retinopathy: operation of the North Wales diabetic retinopathy screening programme using a central patient register and various screening methods.
    J Med Screen, 13(2): 87-92. [Abstract] [Full-text]
34. Converting principal meridional representation of power to the coordinates of the power matrix using the matrix similarity transform.
    Ophthalmic Physiol Opt, 26(4): 426-30. [Abstract] [Full-text]
35. Visual impairment and the useful field of vision.
    Ophthalmic Physiol Opt, 26(4): 392-403. [Abstract] [Full-text]
36. Non-contact tonometry synchronized with cardiac rhythm and its relationship with blood pressure.
    Ophthalmic Physiol Opt, 26(4): 384-91. [Abstract] [Full-text]
37. The exponential-mean-log-transference as a possible representation of the optical character of an average eye.
    Ophthalmic Physiol Opt, 26(4): 380-3. [Abstract] [Full-text]
38. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance.
    Ophthalmic Physiol Opt, 26(4): 362-71. [Abstract] [Full-text]
39. Fusidic acid viscous eyedrops--an evaluation of pharmacodynamics, pharmacokinetics and clinical use for UK optometrists.
    Ophthalmic Physiol Opt, 26(4): 343-61. [Abstract] [Full-text]
40. Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation.
    Invest Ophthalmol Vis Sci, 47(7): 3187-94. [Abstract] [Full-text]
41. Arginine 54 and Tyrosine 118 residues of {alpha}A-crystallin are crucial for lens formation and transparency.
    Invest Ophthalmol Vis Sci, 47(7): 3004-10. [Abstract] [Full-text]
42. Effects of orthoptic treatment on the CA/C and AC/A ratios in convergence insufficiency.
    Invest Ophthalmol Vis Sci, 47(7): 2876-80. [Abstract] [Full-text]
43. Perceived barriers to care and attitudes about vision and eye care: focus groups with older African Americans and eye care providers.
    Invest Ophthalmol Vis Sci, 47(7): 2797-802. [Abstract] [Full-text]
44. What healthcare students do with what they don't know: the socializing power of 'uncertainty' in the case presentation.
    Commun Med, 3(1): 81-92. [Abstract] [Full-text]

© 2005-2008 Optometry Research Today. All Rights Reserved.